Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil

International Journal of Pharmaceutics

Volumn 361, Issue 1-2, 2008, Pages 230-238

  Venuganti, Venkata Vamsi K ^a   Perumal, Omathanu P ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

5 Fluorouracil; Epidermis vehicle partitioning; Flux; Isopropyl myristate; Mineral oil; PAMAM dendrimer; Skin resistance; Transepidermal water loss

Indexed keywords

CARBON 14; DENDRIMER; FLUOROURACIL; MINERAL OIL; MYRISTIC ACID ISOPROPYL ESTER; PHOSPHATE; POLYAMIDOAMINE; SODIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DRUG PENETRATION; DRUG SOLUBILITY; ISOTOPE LABELING; LIPOPHILICITY; LIQUID SCINTILLATION COUNTING; NONHUMAN; PARTITION COEFFICIENT; PRIORITY JOURNAL; SKIN CONDUCTANCE; SKIN PERMEABILITY; SKIN WATER LOSS; SWINE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; DENDRIMERS; DIFFUSION; FLUOROURACIL; MINERAL OIL; MYRISTATES; PERMEABILITY; PHOSPHATES; POLYAMINES; SKIN ABSORPTION; SOLUBILITY; SWINE; VEHICLES;

EID: 47949085542     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.05.034     Document Type: Article

References (45)

1. Akimoto T., Aoyagi T., Minoshima J., and Nagase Y. Polymeric percutaneous drug penetration enhancer. Synthesis and enhancing property of PEG/PDMS block copolymer with a cationic end group. J. Control. Rel. 49 (1997) 229-241
2. Aoyagi T., Terashima O., Suzuki N., Matsui K., and Nagase Y. Polymerization of benzalkonium chloride-type monomer and application to percutaneous drug absorption enhancer. J. Control. Rel. 13 (1990) 63-71
3. Aoyagi T., Terashima O., Nagase Y., and Matsui K. Preparation of a polymer containing hexadecylpyridinium bromide groups and its utilization as a transdermal drug penetration enhancer. Polymer 32 (1991) 2106-2111
4. Aungst B.J., Blake J.A., and Hussain M.A. Contributions of drug solubilization, partitioning, barrier disruption and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines. Pharm. Res. 7 (1990) 712-718
5. Beall H.D., Getz J.J., and Sloan K.B. The estimation of relative water solubility for prodrugs that are unstable in water. Int. J. Pharm. 93 (1993) 37-47
6. Beall H.D., and Sloan K.B. Topical delivery of 5-fluorouracil (5-FU) by 1, 3-bisalkylcarbonyl-5-FU prodrugs. Int. J. Pharm. 231 (2002) 43-49
7. Burnette R.R., and Ongpipattanakul B. Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76 (1987) 765-773
8. Chauhan A.S., Sridevi S., Chalasani K.B., Jain A.K., Jain S.K., Jain N.K., and Diwan P.V. Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin. J. Control. Rel. 90 (2003) 335-343
9. Cheng Y., Xu Z., Ma M., and Xu T. Dendrimers as drug carriers: Applications in different routes of drug administration. J. Pharm. Sci. 97 (2008) 123-143
10. Cornwell P.A., and Barry B.W. The routes of penetration of ions and 5-fluorouracil across human skin and the mechanisms of action of terpene skin penetration enhancers. Int. J. Pharm. 94 (1993) 189-194
11. D'Emanuele A., and Attwood D. Dendrimer-drug interactions. Adv. Drug Deliv. Rev. 57 (2005) 2147-2162
12. Diallo M.S., Christie S., Swaminathan P., Balogh L., Shi X., Um W., Papelis C., Goddard W.A., and Johnson Jr. J.H. Dendritic chelating agents. 1. Cu(II) Binding to ethylene diamine core poly(amidoamine) dendrimers in aqueous solutions. Langmuir 20 (2004) 2640-2651
13. Elias P.M., and Friend D.S. The permeability barrier in mammalian epidermis. J. Cell Biol. 65 (1975) 180-191
14. Esfand R., and Tomalia D.A. Poly(amidoamine) (PAMAM) dendrimer: from biomimicry to drug delivery and biomedical applications. Drug Discov. Today 6 (2001) 427-436
15. Gao S., and Singh J. Mechanism of transdermal transport of 5-fluorouracil by terpenes: carvone, 1,8-cineole and thymol. Int. J. Pharm. 154 (1997) 67-77
16. Gao S., and Singh J. Effect of oleic acid/ethanol and oleic acid/propylene glycol on the in vitro percutaneous absorption of 5-fluorouracil and tamoxifen and the macroscopic barrier property of porcine epidermis. Int. J. Pharm. 165 (1998) 45-55
17. Gardikis K., Hatziantoniou S., Viras K., Wagner M., and Demetzos C. A DSC and Raman spectroscopy study on the effect of PAMAM dendrimer on DPPC model lipid membranes. Int. J. Pharm. 318 (2006) 118-123
18. Goette D.K. Topical chemotherapy with 5-fluorouracil. A review. J. Am. Acad. Dermatol. 4 (1981) 633-649
19. Goodman M., and Barry B.W. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J. Invest. Dermatol. 91 (1988) 323-327
20. Hadgraft J., Walter K.A., and Wotton P.K. Facilitated percutaneous absorption: a comparison and evaluation of two in vitro models. Int. J. Pharm. 32 (1968) 257-263
21. Higuchi T. Physicochemical analysis of percutaneous absorption process from creams and ointments. J. Soc. Cosmet. Chem. 11 (1960) 85-97
22. Kalia Y.N., Pirot F., and Guy R.H. Homogenous transport in a heterogenous membrane: water diffusion across human stratum corneum in vivo. Biophys. J. 71 (1996) 2692-2700
23. Kitchens K.M., El-Sayed M., and Ghandehari H. Transepithelial and endothelial transport of poly(amidoamine) dendrimers. Adv. Drug Deliv. Rev. 57 (2005) 2163-2176
24. Kligman A.M., and Christopher E. Preparation of isolated sheets of human stratum corneum. Arch. Dermatol. 88 (1963) 70-73
25. Lee W.R., Shen S.C., Wang K.H., Hu C.H., and Fang J.Y. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. J. Pharm. Sci. 91 (2002) 1613-1626
26. Mammen M., Choi S.-K., and Whitesides G.M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. 37 (1998) 2754-2794
27. Mecke A., Uppuluri S., Sassanella T.M., Lee D.K., Ramamoorthy A., Baker Jr. J.R., Orr B.G., and Banaszak Holl M.M. Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chem. Phys. Lipids 132 (2004) 3-14
28. Meidan V.M., Walmsley A.D., Docker M.F., and Irwin W.J. Ultrasound-enhanced diffusion into coupling gel during phonophoresis of 5-fluorouracil. Int. J. Pharm. 185 (1999) 205-213
29. Merino V., Lopez A., Kalia Y.N., and Guy R.H. Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm. Res. 16 (1999) 758-761
30. Moghimi H.R., Williams A.C., and Barry B.W. A lamellar matrix model for stratum corneum intercellular lipids IV: effects of terpene penetration enhancers on the permeation of 5-fluorouracil and oestradiol through the matrix. Int. J. Pharm. 145 (1996) 49-59
31. Pfister W.R., and Hsieh D.S.T. Permeation enhancers compatible with transdermal drug delivery systems. Pharm. Technol. 14 (1990) 132-138
32. Prausnitz M.R., Mitragotri S., and Langer R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 3 (2004) 115-124
33. Rastogi S.K., and Singh J. Lipid extraction and transport of hydrophilic solutes through porcine epidermis. Int. J. Pharm. 225 (2001) 75-82
34. Rosado C., Cross S.E., Pugh W.J., Roberts M.S., and Hadgraft J. Effect of vehicle pretreatment on the flux, retention and diffusion of topically applied penetrant in vitro. Pharm. Res. 20 (2003) 1502-1507
35. Rothbard J.B., Jessop T.C., and Wender P.A. Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. Adv. Drug Deliv. Rev. 57 (2005) 495-504
36. Shcharbin D., Drapeza A., Loban V., Lisichinok A., and Bryszewska M. The breakdown of bilayer lipid membranes by dendrimers. Cell Mol. Biol. Lett. 11 (2006) 242-248
37. Sherertz E.F., Sloan K.B., and McTierman R.G. Use of theoretical partition coefficients determined from solubility parameters to predict permeability coefficients for 5-fluorouracil. J. Invest. Dermatol. 89 (1987) 147-151
38. Sherertz E.F., Sloan K.B., and McTierman R.G. Transdermal delivery of 5-fluorouracil through skin of hairless mice and humans in vitro: a comparison of the effect of formulations and a prodrug. Arch. Dermatol. Res. 282 (1990) 463-468
39. Singh B.N., Singh R.B., and Singh J. Effects of ionization and penetration enhancers on the transdermal delivery of 5-fluorouracil through excised human stratum corneum. Int. J. Pharm. 298 (2005) 98-107
40. Tsuji T., and Sugai T. Topically administered fluorouracil in psoriasis. Arch. Dermatol. 105 (1975) 208-212
41. Uppuluri, S., Dvornic, P.R., Tan, N.C.B., Hagnauer, G., 1999. The properties of dendritic polymers II: generation dependence of the physical properties of poly(amidoamine) dendrimers. US Army Research Laboratory Report, Aberdeen Proving Ground, MD, January, pp. 13-14.
42. Wester R.C., and Maibach H.I. Penetration enhancement by skin hydration. In: Smith E.W., and Maibach H.I. (Eds). Percutaneous Penetration Enhancers (1995), CRC Press, Boca Rotan, FL 21-28
43. Williams A.C., and Barry B.W. Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement. Pharm. Res. 8 (1991) 17-24
44. Williams A.C., and Barry B.W. Penetration enhancers. Adv. Drug Deliv. Rev. 56 (2004) 603-618
45. Yiyun C., Na M., Tongwen X., Rongqiang F., Xueyuan W., Xiaomin W., and Longpin W. Transdermal delivery of nonsteroidal anti-inflammatory drug mediated by polyamidoamine (PAMAM) dendrimers. J. Pharm. Sci. 96 (2007) 562-595